PubRank

M Knoop

Author PubWeight™ 18.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat. Transplantation 1992 1.23
2 [Experiences with simultaneous exploration of the bile ducts in surgical therapy of gallstone ileus]. Chirurg 1993 0.93
3 Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions. Hepatology 1996 0.91
4 Effect of caseload on the short-term outcome of colon surgery: results of a multicenter study. Int J Colorectal Dis 2001 0.87
5 Is orthotopic liver transplantation for end-stage alcoholic cirrhosis justified? Transplant Proc 1995 0.87
6 A liver with polycystic liver disease as graft for orthotopic liver transplantation. Clin Transplant 1998 0.86
7 [Extended partial Kausch-Whipple duodenopancreatectomy by resection of tumor infiltrated vascular segments]. Zentralbl Chir 1995 0.83
8 Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. Transplantation 1995 0.83
9 Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo-controlled study. Clin Transplant 1997 0.82
10 Phenotypic characterization of T-suppressor lymphocytes induced by orthotopic rat liver transplantation. Transplant Proc 1989 0.81
11 [Dubowitz syndrome]. Ergeb Inn Med Kinderheilkd 1988 0.80
12 Mycophenolate mofetil added to immunosuppression after liver transplantation--first results. Transpl Int 1997 0.79
13 Factors relevant to the development of primary dysfunction in liver allografts. Transplant Proc 1995 0.79
14 [Review of the physical and surgical technical properties of modern monofilament suture materials]. Chirurg 1986 0.78
15 Effective therapy for hepatic M. Osler with systemic hypercirculation by ligation of the hepatic artery and subsequent liver transplantation. Transpl Int 1998 0.77
16 Donor MEGX test fails to predict graft function after orthotopic liver transplant. Transplant Proc 1997 0.77
17 Combined liver-kidney transplantation: long-term follow up in 18 patients. Transpl Int 1998 0.76
18 Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis. Transplant Proc 1994 0.76
19 A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation. Transplantation 1997 0.76
20 Selection of small hepatocellular carcinoma improves long-term results of hepatic transplantation for malignancy. Transpl Int 1994 0.76
21 Does concommitant splenectomy raise the mortality of liver transplant recipients? Transpl Int 1994 0.76
22 Reconstruction of bile duct using the side-to-side anastomosis in 389 orthotopic liver transplantations. Transplant Proc 1995 0.75
23 Prevention of liver allograft rejection in rats by a short course of therapy with Brequinar Sodium. Transplantation 1992 0.75
24 Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation? Transplant Proc 1996 0.75
25 A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLT. Transplant Proc 1998 0.75
26 [Partial hepatectomy after post-traumatic liver abscess]. Chirurg 1998 0.75
27 Quadruple immunosuppression including a new IL-2-receptor antibody and the incidence of infections after liver transplantation. Transpl Int 1992 0.75
28 Terahertz frequency standard based on three-photon coherent population trapping. Phys Rev Lett 2007 0.75
29 [Liver transplantation as a routine procedure? Indications and results in 270 patients]. Fortschr Med 1993 0.75
30 Liver transplantation in HBsAg+ patients with postoperative immunoprophylaxis. Transplant Proc 1997 0.75
31 [Accounting practices (I)]. Quintessenz J 1981 0.75
32 [Collection and settlement of fixed fees]. Quintessenz J 1981 0.75
33 A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation. Clin Transplant 1998 0.75
34 The importance of late infections for the long-term outcome after liver transplantation. Transpl Int 1996 0.75
35 [Graft-vs.-host reaction: a severe complication after orthotopic liver transplantation]. Zentralbl Chir 1995 0.75
36 [Nomenclature and interpretation of concepts in pharmacology]. Quintessenz J 1981 0.75
37 Analysis of risk factors for recurrence of hepatocellular carcinoma after orthotopic liver transplantation. Transplant Proc 1995 0.75
38 [Surgical interventional endoscopic treatment concept of bile duct lesions after laparoscopic cholecystectomy]. Langenbecks Arch Chir Suppl Kongressbd 1998 0.75
39 Impact of immunosuppression in liver transplantation across a positive crossmatch. Transplant Proc 1998 0.75
40 [Accounting practice (III)]. Quintessenz J 1982 0.75
41 [Interim prosthesis--immediate prosthesis]. Quintessenz J 1981 0.75
42 Incidence of biliary complications following side-to-side choledochocholedochostomy after liver transplantation. Transplant Proc 1994 0.75
43 [Accounting practices (IV)]. Quintessenz J 1982 0.75
44 Suprahepatic vena cava cuffs in rat liver transplantation--a simplified method? Transplantation 1989 0.75
45 Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation. Transplant Proc 1998 0.75
46 The validity of the MEGX test in correlation with histology after orthotopic rat liver transplantation. Transpl Int 1994 0.75
47 Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial. Transplant Proc 1995 0.75
48 [Application for and settlement of orthodontic treatment]. Quintessenz J 1981 0.75
49 [Technique of microvascular jejunum transfer for replacement of the cervical esophagus]. Chirurg 1991 0.75
50 Immunosuppression and incidence of opportunistic pneumonias after liver transplantation. Transplant Proc 1998 0.75
51 [Necessity for dental documentation and its preservation]. Quintessenz J 1981 0.75
52 [Accounting practice (II)]. Quintessenz J 1981 0.75
53 [Maxon and PDS--evaluation and physical and biologic properties of monofilament absorbable suture materials]. Langenbecks Arch Chir 1987 0.75
54 Impact of donor factors on postoperative liver function after orthotopic rat liver transplantation. Transplant Proc 1998 0.75
55 Surgical concepts for therapy of pancreatic neoplasms. Recent Results Cancer Res 1996 0.75
56 Antithymocyte globulin or interleukin 2 receptor antibody for immunosuppressive induction therapy after orthotopic liver transplantation: a follow-up study. Transplant Proc 1993 0.75
57 [Application for and settlement of orthodontic treatment]. Quintessenz J 1981 0.75
58 [A tentative model in family therapy (author's transl)]. Psychother Med Psychol (Stuttg) 1979 0.75
59 Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study. Transplant Proc 1996 0.75
60 Positive donor cytomegalovirus IgG status as a major risk factor for liver allograft recipient infection. Transplant Proc 1997 0.75
61 Protection of rectal anastomoses by transanal decompressive tubing. Tech Coloproctol 2003 0.75
62 Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. Transplant Proc 1995 0.75
63 [Impression technics and compensation for them]. Quintessenz J 1981 0.75